CD225 Polyclonal Antibody

IFN-induced antiviral protein that mediate cellular innate immunity to at least three major human pathogens, namely influenza A H1N1 virus, West Nile virus, and dengue virus by inhibiting the early step(s) of replication. Plays a key role in the antiproliferative action of IFN-gamma either by inhibiting the ERK activition or by arresting cell growth in G1 phase in a p53-dependent manner. Implicated in the control of cell growth. Component of a multimeric complex involved in the transduction of antiproliferative and homotypic adhesion signals.

Introducing the CBP (Acetyl Lys1535) Polyclonal Antibody, a highly reliable and efficient tool for various research applications. This antibody has been meticulously developed using advanced techniques to ensure exceptional specificity and sensitivity.

The CBP (Acetyl Lys1535) Polyclonal Antibody is designed to target the acetylated lysine residue at position 1535 of the CBP protein. It has been extensively validated for its ability to recognize and bind to this specific epitope with utmost precision. This antibody exhibits minimal cross-reactivity with other proteins, ensuring accurate and reliable results.

With its exceptional sensitivity, the CBP (Acetyl Lys1535) Polyclonal Antibody enables the detection of even low-abundance CBP protein levels. This feature makes it an ideal choice for a wide range of applications, including Western blotting, immunohistochemistry, and immunofluorescence.

The CBP (Acetyl Lys1535) Polyclonal Antibody is manufactured using high-quality materials and undergoes rigorous quality control procedures to guarantee consistent performance and reproducibility. It is supplied as a liquid formulation, allowing for easy handling and convenient storage.

In summary, the CBP (Acetyl Lys1535) Polyclonal Antibody is a reliable and efficient tool for researchers seeking to investigate the acetylation status of the CBP protein. Its exceptional specificity, sensitivity, and ease of use make it an invaluable asset in various research applications.